title: Intravenous luteinizing hormone-releasing hormone has no effect on serum N-terminal pro-brain natriuretic peptide in children and adolescents.
abstract: BACKGROUND
  Little is known about the acute effects of i.v. luteinizing hormone-releasing hormone (LHRH) on the heart function, therefore the aim of the present study was to measure N-terminal pro-brain natriuretic peptide (N-BNP) in children, who underwent a diagnostic work up for short stature or delayed puberty.
  
  
  METHODS
  N-BNP was measured in 52 children before and after administration of LHRH. Serum N-BNP obtained from 255 healthy children and adolescents (aged birth-18.3 years) served as a reference.
  
  
  RESULTS
  There was no significant difference between baseline N-BNP of children who underwent the LHRH diagnostic test and their healthy peers. There was no significant serum N-BNP level change before or after administration of LHRH (59 +/- 36 pg/mL vs 58 +/- 34 pg/mL). N-BNP fell from 399 +/- 425 pg/mL in newborns and reached 44 +/- 36 pg/mL in children aged 12-18 years.
  
  
  CONCLUSIONS
  Short stature or delayed puberty had no effect on heart function determined by serum N-BNP; i.v. LHRH does not acutely influence the level of serum N-BNP.
authors.affiliation: Department of Paediatric Cardiology and Intensive Care Medicine, Medical School Hannover, Hannover, Germany. kambiz@mh-hannover.de
authors.forename: Kambiz
authors.initials: K
authors.lastname: Norozi
authors.forename: Lutz
authors.initials: L
authors.lastname: Binder
authors.forename: Christoph
authors.initials: C
authors.lastname: Brack
authors.forename: Ludger
authors.initials: L
authors.lastname: Potthoff
authors.forename: Georg
authors.initials: G
authors.lastname: Hess
authors.forename: Armin
authors.initials: A
authors.lastname: Wessel
mesh_terms: D000293:Adolescent; D000450:Aldosterone / Q000097:blood; D001827:Body Height / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D009638:Norepinephrine / Q000097:blood; D010446:Peptide Fragments / Q000097:blood*; D011628:Puberty, Delayed / Q000188:drug therapy; D012016:Reference Values
chemical_list: D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D007987:Gonadotropin-Releasing Hormone; D000450:Aldosterone; D009638:Norepinephrine